Study Name:
KEYMAKER-U01 Substudy 01H: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC)
Targeted Disease(s):
Lung Cancer
Purpose of Study:
Researchers will compare 2 different ADCs (the study treatments) to chemotherapy in this study. The goals of this study are to learn 1) about the safety of the study treatments and if people tolerate them and 2) how many people have the cancer respond to the study treatments.
Study Dates:
May 13, 2025 - March 12, 2032
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
Multi-center Trial
Sponsors:
Merck Sharp & Dohme LLC
Contact:
Phone: 1-888-577-8839
Email: [email protected]
ClinicalTrails.gov Identifier:
NCT06780085
